New Life Pharma LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Last warning letter 2026
Inspections 0 0 OAI
Recalls 4 0 Class I (0%)
Warning letters 1 Latest Apr 14, 2026
510(k) clearances 0 None on file

New Life Pharma LLC has 4 FDA recalls, 0 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to New Life Pharma LLC, the most recent on Apr 14, 2026.

What these totals cover: FDA records filed under the name "New Life Pharma LLC" and its spelling variant "New Life Pharma".

Latest recall
D-0394-2026 · Class II · Feb 26, 2026

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls4Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections0Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing New Life Pharma LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check New Life Pharma LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

New Life Pharma LLC FDA Warning Letters

1 warning letter on Apr 14, 2026.

IssuedSubjectIssuing officeClose-out letter
Apr 14, 2026 · Letter on fda.gov CGMP/Adulterated and Unapproved New Drug/MisbrandedCenter for Drug Evaluation and Research (CDER)

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

4 recall records on Feb 26, 2026.

NumberClassProductDate
D-0394-2026Class IITirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106…Feb 26, 2026
D-0393-2026Class IISemaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite…Feb 26, 2026
D-0395-2026Class IITirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106…Feb 26, 2026
D-0392-2026Class IISemaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106…Feb 26, 2026

Compliance Actions

FDA's compliance actions data lists 1 compliance action under New Life Pharma LLC: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Apr 14, 2026.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

New Life Pharma LLC and the FDA: common questions

Has New Life Pharma LLC received an FDA warning letter?

Yes. FDA has issued 1 warning letter to New Life Pharma LLC. The most recent is dated Apr 14, 2026, with the subject "CGMP/Adulterated and Unapproved New Drug/Misbranded".

Has New Life Pharma LLC received an FDA Form 483?

FDA has not published a Form 483 for "New Life Pharma LLC" in its reading room. FDA publishes some Form 483s, not all of them.

Has New Life Pharma LLC had an FDA recall?

Yes. New Life Pharma LLC has 4 FDA recalls on record. The most recent started Feb 26, 2026.

Need more than this page shows? Ask about New Life Pharma LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.